000			01607nam a2200349 a 4500
001			ebr10286191
003			CaPaEBR
006			m u
007			cr cn|||||||||
008			090925s2009 dcua sb 000 0 eng d
020			_z9780309120883
020			_z0309120888
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)726823396
043			_an-us---
050	1	4	_aRA401.A3 _bB74 2009eb
245	0	0	_aBreakthrough business models _h[electronic resource] : _bdrug development for rare and neglected diseases and individualized therapies : workshop summary / _cTheresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
260			_aWashington, D.C. : _bNational Academies Press, _c2009.
300			_a149 p. : _bill.
504			_aIncludes bibliographical references (p. 104-105).
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aOrphan drugs _xGovernment policy _zUnited States.
650		0	_aPharmaceutical policy _zUnited States.
650		0	_aDrugs _xDesign _zUnited States.
655		7	_aElectronic books. _2local
700	1		_aWizemann, Theresa M.
700	1		_aRobinson, Sally.
700	1		_aGiffin, Robert B.
710	2		_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation.
710	2		_aebrary, Inc.
856	4	0	_uhttp://site.ebrary.com/lib/rucke/Doc?id=10286191 _zAn electronic book accessible through the World Wide Web; click to view
999			_c2080 _d2080